Results 1 to 10 of about 21,753 (168)

Ruthenium Anticancer Compounds: Challenges and Expectations

open access: yesCHIMIA, 2007
Two ruthenium compounds, namely [ImH]trans-[RuCl4(Im)(dmso-S)] (NAMI-A, Im = imidazole) and [IndH] trans-[RuCl4(Ind)2] (KP1019, Ind = indazole) have already completed phase I clinical trials as anticancer agents.
Ioannis Bratsos   +3 more
doaj   +5 more sources

Nucleosome acidic patch-targeting binuclear ruthenium compounds induce aberrant chromatin condensation [PDF]

open access: yesNature Communications, 2017
Histone H2A–H2B dimers in nucleosomes contain an acidic patch, a highly electronegative cleft. Here, the authors characterize a family of binuclear ruthenium compounds that selectively target the acidic patch, generating intra-nucleosomal H2A-H2B cross ...
Gabriela E. Davey   +11 more
doaj   +2 more sources

Pt-Ru Alloy Catalysts with Doped CeO2 Interlayer for Methane Conversion [PDF]

open access: yes한국정밀공학회지, 2020
The necessity of converting toxic gas has arisen from the usage of perfluorinated compounds (PFCs), volatile organic compounds (VOCs), and hydrocarbon gases in the semiconductor process and laboratories.
Min Jong Kil   +9 more
doaj   +1 more source

The Behavior of Ruthenium in Copper Electrowinning

open access: yesMetals, 2022
The recycling of material containing precious metals can lead to the entry of ruthenium into the copper electrowinning process, by so far unknown effects. There, ruthenium is oxidized to highly volatile ruthenium tetroxide.
Alexandra Thiere   +2 more
doaj   +1 more source

New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents

open access: yesPharmaceutics, 2023
The combination of one molecule of organic and metal-based fragments that exhibit antitumor activity is a modern approach in the search for new promising drugs.
Ilya A. Shutkov   +8 more
doaj   +1 more source

Anti-Inflammatory Mechanisms of Novel Synthetic Ruthenium Compounds

open access: yesApplied Sciences, 2021
Inflammation is the primary biological reaction to induce severe infection or injury in the immune system. Control of different inflammatory cytokines, such as nitric oxide (NO), interleukins (IL), tumor necrosis factor alpha-(TNF-α), noncytokine ...
Thanasekaran Jayakumar   +4 more
doaj   +1 more source

Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer

open access: yesPharmaceutics, 2021
Despite some limitations such as long-term side effects or the potential presence of intrinsic or acquired resistance, platinum compounds are key therapeutic components for the treatment of several solid tumors. To overcome these limitations, maintaining
Elena Domínguez-Jurado   +8 more
doaj   +1 more source

Mechanochemical synthesis of intermetallic compounds in the system gallium – ruthenium

open access: yesChimica Techno Acta, 2021
The interaction of a solid inert metal Ru with liquid active metal Ga during mechanical activation in a high-energy planetary ball mill was studied using the X-ray diffraction and the high resolution scanning electron microscopy with energy dispersive X ...
T. F. Grigoreva   +3 more
doaj   +1 more source

Antioxidant activity of new ruthenium compounds [PDF]

open access: yesRedox Report, 2005
Many biological properties have been attributed to ruthenium complexes including anti-tumor activity and the attenuation of reperfusion damage and infarct size. In this work, we characterize the antioxidant activity of trans-[RuCl2(nic)4] where nic is 3-pyridinecarboxylic acid and trans-[RuCl2(i-nic)4] where i-nic is 4-pyridinecarboxylic acid by (i ...
Marcos Marques da Silva, Paula   +9 more
openaire   +2 more sources

Dichloro[N-[(η6-phenyl)methyl]-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8tetrahydronaphthalen-2-yl)vinyl)benzamide](1,3,5-triaza-7-phosphatricyclo [3.3.1.13,7]decane-κP7)ruthenium

open access: yesMolbank, 2022
Bexarotene-tethered RuII(arene) compounds with 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane (PTA) were prepared as an analog of RAPTA antitumor complexes in order to evaluate their in vitro antiproliferative activity against human cancer cell lines.
Ilya A. Shutkov   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy